Dr. Philip M Arlen to deliver to presentations on the NEO-201 program at the Molecular Med Tri-Con Meetings, March 10-15th, SF, CA

The Discovery and Development of Novel Monoclonal Antibody, NEO-201 Targeting a Novel Neoantigen

Philip M. Arlen, M.D.March, 2019

Download the presentation (PDF)

Neoantigen Based Immunotherapies

Executive Summit on Cancer Immunotherapy